Pfenex And Hospira Collaboration To Develop And Commercialize LUCENTIS® Biosimilar
Pfenex Inc, a clinical-stage biotechnology company engaged in the development of biosimilar therapeutics, and Hospira, Inc., (NYSE: HSP), the world’s leading provider... Read More